Live Feeds

Source map — Amgen drug combined with immunotherapy extends survival in lung cancer trial

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
CNBC news 60%
Amgen news 60%
NBC News news 60%
Fierce Pharma news 60%
Reuters news 60%
Bloomberg.com news 60%
Bioengineer.org news 60%
www.cnbc.com news 50%
www.marketscreener.com news 50%
arynews.tv news 50%
www.yahoo.com news 50%
ca.marketscreener.com news 50%
www.amgen.com news 50%
pharma.economictimes.indiatimes.com news 50%
www.healthandme.com news 50%